ILMN
Illumina, Inc.
$198.30
▼ -3.32%
−$6.80
NYSE · Healthcare · Diagnostics & Research
· price updated 9h ago
Illumina, Inc.
ILMN · NYSE · Healthcare · Diagnostics & Research · price updated 9h ago
$198.30
▼ -3.32% · −$6.80 today
AI research · $198.30
Track ILMN for continuous AI research
price position
Where ILMN sits now
52-week range
Low$88.00
High$196.66
Today $198.30
RSI (14)
53.4Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$1.2B
Total debt$2.4B
Net cash after debt$-1.3B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 67% above Sector avg
36.26x
Price / sales
Value assigned to each sales dollar
Reasonable · Between 3x and 8x sales
6.89x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
33.27x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
28.01x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Strong · At least 15% return on capital
17.4%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
32.3%
Debt / equity
Balance-sheet leverage
Middle ground · Roughly in line with sector
0.89x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
1.80x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How ILMN compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $31.03B | 38.2 | +4.9% | 58 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Illumina, Inc. (ILMN) stock
Illumina, Inc. tracked in the US core universe. ILMN was -3.3% in the latest available session at $198.30. Its reported market value was $31.03B with a trailing P/E of 38.2. Latest reported revenue was $4.49B, changing +4.9% year over year, with $825.00M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $198.30
- Day change
- -3.3%
- Market cap
- $31.03B
- P/E (TTM)
- 38.2
- Revenue growth
- +4.9%
- Industry
- Diagnostics & Research